ANI Pharmaceuticals rare-disease head disposes of $30,858 in shares as company posts strong Q4
Christopher Mutz, Head of Rare Disease at ANI Pharmaceuticals Inc. (NASDAQ: ANIP), sold 417 shares on March 2, 2026, receiving $74 per share for a total of $30,858. The transaction occurred as ANIP shares traded near $76.53. The company has reported robust fundamentals, including 44% revenue growth and a market capitalization of $1.6 billion, and p…